News Conference News AHA 2021 Empagliflozin Retains Benefits in ‘True’ HFpEF Patients Todd Neale November 17, 2021
News Conference News Trial of Cell Therapy for HF Misses Primary Endpoint, but Signals a Path Forward Todd Neale November 16, 2021
News Conference News AHA 2021 Canagliflozin Improves Quality of Life in HF Patients Michael O'Riordan November 16, 2021
News Conference News AHA 2021 An Oral PCSK9 Inhibitor? Early Data Show Safety, Big LDL Drops Shelley Wood November 15, 2021
News Conference News AHA 2021 Empagliflozin Safe in Acute HF, Improves ‘Clinical Benefit’ Over Time: EMPULSE Shelley Wood November 14, 2021
News Conference News AHA 2021 Fitbit Joins the AF Hunt, but Effect on Treatment, Outcomes Unknown Yael L. Maxwell November 14, 2021
News Conference News AHA 2021 External Support for Vein Grafts in CABG Doesn’t Help Patency: VEST Yael L. Maxwell November 14, 2021
News Conference News TCT 2021 Conservative Management, Careful Diagnosis Key for Good SCAD Outcomes Yael L. Maxwell November 09, 2021
News Conference News TCT 2021 DCBs in Coronaries? Some Good News, but More Work Needed L.A. McKeown November 06, 2021
News Conference News TCT 2021 Transcatheter Mitral, Tricuspid Valve Replacement Inch Forward Yael L. Maxwell November 06, 2021
News Conference News TCT 2021 OPTIMIZE: 2-Year DES Data Affirm Need for Meaningful MI Definitions L.A. McKeown October 25, 2021
News Conference News EACTS 2021 Left Main Guideline Review Looms as EACTS Surgeons Urge CABG First Michael O'Riordan October 19, 2021
News Conference News VIVA 2021 Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI L.A. McKeown October 08, 2021
News Conference News VIVA 2021 Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms L.A. McKeown October 07, 2021
News Conference News AHA Announces Fully Virtual Meeting in Light of Surging COVID-19 Numbers Michael O'Riordan September 17, 2021
News Conference News ESC 2021 OAC Analysis From MASTER DAPT Raises No Red Flags for Shorter DAPT Shelley Wood September 02, 2021
News Conference News ESC 2021 2021 ESC/EACTS Valve Guidelines Unveil TAVI/SAVR Age Cutoffs and Earlier Care Shelley Wood August 31, 2021
News Conference News ESC 2021 New ESC HF Guidelines Showcase SGLT2 Inhibitors, Tafamidis, Vericiguat, and COAPT Shelley Wood August 28, 2021
News Conference News ESC 2021 EMPEROR-Preserved: Empagliflozin Improves Outcomes in HFpEF Todd Neale August 27, 2021
News Conference News ESC 2021 Prasugrel Tops Ticagrelor in ACS Across the eGFR Spectrum: ISAR-REACT 5 Todd Neale August 24, 2021